Endoscopic and Histopathological Findings, and The Presence of Helicobacter Pylori in Diabetic and NonDiabetic Patients Admitted to the Emergency Department with Dyspeptic Complaints

The patients presenting with dyspeptic complaints constitute a significant rate among all patients. We investigated theendoscopic findings and the presence of Helicobacter pylori (HP) in patients who presented to the emergency departmentwith dyspeptic complaints.Patients, who presented to the emergency department of our hospital with dyspeptic complaints and underwent anendoscopic examination of the upper gastrointestinal system between February/2018 and September/2019, were includedin the study. The demographic characteristics of the patients, the treatments they were administered, and the data onsmoking and alcohol consumption were documented. Endoscopic findings and histopathological data of the patients weredocumented. It was examined whether there was a statistical difference between the diabetic and non-diabetic groups.A total of 100 patients were included in the study. The DM group consisted of 50 patients in total, 30(60%) female; andthe non-DM group consisted of 50 patients in total, 28(56%) female. The most common endoscopic finding in bothgroups was pangastritis. According to the comparison made between the groups in terms of endoscopic findings; the laxityof the LES was found in the non-DM group with a statistically higher rate (p=0.027). However, other endoscopic findingsand the presence of HP were similar in both groups (p>0.05).While pangastritis was frequently present in patients presenting with dyspepsia in the emergency department, there was nosignificant difference between diabetic and non-diabetic groups in terms of endoscopic findings and presence of HP.

PDF

___

1. Sen S, Chakraborty R. Treatment and Diagnosis of Diabetes Mellitus and Its Complication: Advanced Approaches. Mini Rev Med Chem 2015; 15: 1132-1133.

2. Schmidt AM. Highlighting Diabetes Mellitus: The Epidemic Continues. Arterioscler Thromb Vasc Biol 2018; 38: 1-8.

3. Ruiz J. Diabetes Mellitus. Rev Med Suisse 2012; 8: 88-90.

4. Satman I, Imamoglu S, Yilmaz C, Akalin S ve Diabetes Mellitus Çalışma ve Eğitim Grubu. TEMD Diabetes Mellitus ve Komplikasyonlarının Tanı, Tedavi ve İzlem Kılavuzu, 5. Baskı. Bayt Matbaacılık, Ankara, 2011.

5. Y Kayar, A Ilhan, NB Kayar, et al. Relationship between the poor glycemic control and risk factors, life style and complications. Biomedical Research 2017; 28: 23-25.

6. Bharucha AE, Kudva YC, Prichard DO. Diabetic Gastroparesis. Endocrine Reviews October 2019; 40: 1318-1352.

7. Standards of Medical Care in diabetes 2020. Diabetes Care 2020; 43: 1-2. 8. American Diabetes Association. Standards of Medical Care in Diabetes. Diabetes Care 2015; 38: 8-67.

9. Guariguata L, Whiting DR, Hambleton I, Beagley J, Linnenkamp U, Shaw JE. Global estimates of diabetes prevalence for 2013 and projections for 2035. Diabetes Res Clin Pract 2014; 103: 137-149.

10. Kayar Y, Pamukcu O, Eroglu H, et al. Relationship between Helicobacter pylori infections in diabetic patients and inflammations, metabolic syndrome, and complications. Int J Chronic Dis. 2015; 2015: 290128.

11. Koch CA, Uwaifo GI. Are gastrointestinal symptoms related to diabetes mellitus and glycemic control? Eur J Gastroenterol Hepatol 2008; 20: 822-825.

12. The TURDEP Group. Population-Based Study of Diabetes and Risk Characteristics in Turkey. Diabetes Care 2002; 25: 1551-1556.

13. The TURDEP Group. Population-Based Study of Diabetes and Risk Characteristics in Turkey, Istanbul, 2010.

14. American Diabetes Association Professional Practice Committee. American Diabetes Association clinical practice recommendations. Diabetes Care January 2013; 36: 1-110.

15. Oner RI, Karincaoglu M. Correlation of dyspeptic symptoms and endoscopic findings in diabetic patient. Medical Science and Discovery 2018; 5: 130-136.

16. Vasihnav BT, Shaikh SR, Bamanikar AA at al. Diagnostic Upper, gastrointestinal Endoskopi and Prevalence of Helicobacter Pylori İnfection in Dispeptic Type 2 Diabetes Mellitus. J Dig Endosc 2018; 9: 53-60.

17. Meldgaard T, Keller J, Olesen AE, at al. Pathophysiology and management of diabetic gastroenteropathy. Ther Adv Gastroenterol 2019; 12: 1-17.

18. Osipenko M.F, Zhuk E.A, Medvedeva O.V. Diabetes mellitus and dyspepsia syndrome. Klin Med (Mosk) 2008; 86: 13-16.

19. Osipenko M.F, Zhuk E.A, Medvedeva O.V. Clinical characteristics of dyspepsia in patients with diabetes mellitus type 2. Ter Arkh 2013; 85: 43-47.

20. Agın M, Kayar Y, Dertli R, Konur S, Bilgili MA. The Relationship Between Helicobacter Pylori and Reflux Esophagitis in Children. Van Med J 2020; 27: 184-189.

21. Konur S, Surmeli N, Bilgili MA, Dertli R, Kayar Y. Is There a Relationship Between Helicobacter Pylori Eradication and Blood Group? East J Med 2020; 25: 422-426.

22. Stanciu OG, Trifan A, Sfarti C, Cojocariu C, Stanciu C. Helicobacter pylori infection in patients with diabetes mellitus. Rev Med Chir Soc Med Nat Iasi. Jan-Mar 2003; 107: 59-65.